As of Nov 27
| +0.05 / +4.55%|
The 4 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 3.25, with a high estimate of 5.50 and a low estimate of 1.50. The median estimate represents a +182.61% increase from the last price of 1.15.
The current consensus among 4 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.